3 Matching Annotations
  1. Jun 2021
  2. theconversation.com theconversation.com
    How long do COVID vaccines take to start working?
    1
    1. lucyparfitt16 29 Jun 2021

      How long do COVID vaccines take to start working? (n.d.). Retrieved June 29, 2021, from https://theconversation.com/how-long-do-covid-vaccines-take-to-start-working-161876?utm_source=twitter&utm_medium=bylinetwitterbutton

      is:webpage lang:en COVID-19 vaccine government care home Pfizer dose clinical trials protection vaccine effectiveness vaccine efficacy research AstraZeneca hospitalization transmission immunity partial vaccination delta variant Australia
    Visit annotations in context

    Tags

    Annotators

    URL

    theconversation.com/how-long-do-covid-vaccines-take-to-start-working-161876
  3. Apr 2021
  4. www.nature.com www.nature.com
    Concerns about SARS-CoV-2 evolution should not hold back efforts to expand vaccination
    1
    1. sophia.sterckx 10 Apr 2021

      Cobey, Sarah, Daniel B. Larremore, Yonatan H. Grad, and Marc Lipsitch. ‘Concerns about SARS-CoV-2 Evolution Should Not Hold Back Efforts to Expand Vaccination’. Nature Reviews Immunology, 1 April 2021, 1–6. https://doi.org/10.1038/s41577-021-00544-9.

      is:article lang:en COVID-19 vaccination expanding vaccination limited supply doses interval between doses disease mortality partial immunity variants vaccine effectiveness naturally induced immunity
    Visit annotations in context

    Tags

    Annotators

    URL

    nature.com/articles/s41577-021-00544-9
  5. Jul 2020
  6. www.thelancet.com www.thelancet.com
    Assessment of patients who tested positive for COVID-19 after recovery
    1
    1. Danaeioak 08 Jul 2020

      Mei, Q., Li, J., Du, R., Yuan, X., Li, M., & Li, J. (2020). Assessment of patients who tested positive for COVID-19 after recovery. The Lancet Infectious Diseases, 0(0). https://doi.org/10.1016/S1473-3099(20)30433-3

      is:article lang:en COVID-19 recovery discharge criteria follow-up positive retest symptomatic asymptomatic disease recurrence transmission clinical management partial immunity
    Visit annotations in context

    Tags

    Annotators

    URL

    thelancet.com/journals/laninf/article/PIIS1473-3099(20)30433-3/fulltext